Alopecia areata - Alopezia Areata
☆ Alemaniako Stiftung Warentest-en 2022ko emaitzetan, ModelDerm-ekin kontsumitzaileen gogobetetasuna apur bat txikiagoa izan zen ordaindutako telemedikuntzako kontsultekin baino.
Alopezia Areata (Alopecia areata) azalaren atzealdean ikusten da. Kasu tipikoetan, bat-batean azalera guztiz leunarekin eta 2-3 cm-ko tamainarekin agertzen da.
relevance score : -100.0%
ReferencesAlopecia areata zure sistema immunologikoak zure ile‑folikuluei erasotzen dien egoera da, eta aldi baterako ile‑galera eragiten du orri gabe. Ile‑galera adabaki gisa ager daiteke edo zure burua edo gorputz osoari eragin dezake, pertsonen % 2 ingururi eragin dezake bere bizitzako etaparen batean. Errore nagusia ile‑folikuluen inguruko babes naturalaren matxura dela dirudi.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata sistema immuneak ile‑folikuluei erasotzen dien egoera da, larruazalean eta gorputzeko beste atal iletsuetan ilea galtzea eraginez. Mundu osoko pertsonen %2 ingururi eragiten du. Edozein adinetan gerta daitekeen arren, haurrengan ohikoagoa da helduetan baino (1,92 % vs. 1,47 %). Emakumezkoek, batez ere 50 urtetik gorakoek, gizonezkoek baino gehiago bizi ohi dute. Kortikoideak zuzenean kaltetutako eremuetan injektatzea topikoki aplikatzeak baino emaitza hobeak eman ditu.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata ile‑folikuluen sistema immunologikoarekin lotutako gaixotasun autoimmune bat dela uste da. Oinarrizko mekanismoak gorputzak bere zelulak ez antzeman edo ez izatea dakar, eta ondorioz ile‑folikuluen suntsipen immunologikoa gertatzen da.
○ Tratamendua ― OTC Drogak
Alopecia areata arina duten pertsona batzuk urtebeteko epean sendatzen dira tratamendurik gabe. Hala ere, jende gehienek larruazaleko ausazko guneetan errepikapenak izaten dituzte.
#Hydrocortisone cream
○ Tratamendua
Esteroide barruko injekzioak tratamendu eraginkorrena dira. Inmunoterapia larruazaleko eremu handiak kaltetzen badira probatu daiteke.
#Triamcinolone intralesional injection
#DPCP immunotherapy